Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Jeffrey Lawrence Bennett

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Bennett, Jeffrey

One or more keywords matched the following items that are connected to Bennett, Jeffrey

Item Type	Name
Academic Article	Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis.
Academic Article	Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Academic Article	Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.
Academic Article	Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Academic Article	Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Academic Article	Discovery of peptoid ligands for anti-aquaporin 4 antibodies.
Academic Article	Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis.
Academic Article	Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.
Academic Article	Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Academic Article	Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases.
Academic Article	Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.
Academic Article	Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
Academic Article	Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.
Academic Article	Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
Academic Article	Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.
Academic Article	Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
Academic Article	Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.
Academic Article	Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.
Academic Article	Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Concept	Antibodies, Anti-Idiotypic
Concept	Antibodies, Monoclonal
Concept	Antibodies, Blocking
Concept	Antibodies
Concept	Antibodies, Viral
Academic Article	Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.
Academic Article	Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Academic Article	Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Academic Article	Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.
Academic Article	Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.
Academic Article	Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.
Grant	Antigen Identification in Occult Chorioretinopathies
Academic Article	Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
Concept	Antibodies, Monoclonal, Humanized
Academic Article	Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Academic Article	Affinity-matured 'aquaporumab' anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders.
Academic Article	Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.
Academic Article	Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
Academic Article	Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
Academic Article	Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses.
Academic Article	Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Academic Article	Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
Academic Article	Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder.
Academic Article	AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Academic Article	In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring.
Academic Article	Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Academic Article	Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations.
Academic Article	Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Academic Article	SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients.
Academic Article	Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1-anchored membrane domains.
Academic Article	Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Grant	Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis

Search Criteria

Antibodies